News
Local anesthetics have transformed clinical practice by enabling a broad range of minor and major procedures with minimal discomfort. Although adverse reactions are frequently reported, genuine ...
New, non-opioid molecule acts like a long-lasting anesthetic, relieving chronic pain for three weeks
BUFFALO, N.Y. – A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust pain relief for up to three weeks, according to the results ...
Pharmaceutical company Avenacy has launched Propofol injectable emulsion, USP, in the U.S. to be used for intravenous general anesthetic and sedation. The drug has been approved by the FDA as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results